The Effect of Mosaic Puzzle Game on Nomophobia in Adolescents

This study aims to investigate the effect of mosaic puzzle application on nomophobia in middle school children aged 12-14.

The data for the study will be collected over a 5-week period. The experimental group children will be asked to play mosaic puzzle games for 1 hour, 2 days a week for 5 weeks, at a time deemed appropriate by the school and under the supervision of the researcher. The control group children will not be given any intervention; they will only be observed, and a final test will be administered at the end of the 5 weeks. The study is planned as a single-center study, and a total of 30 children aged 12-14 with a nomophobia scale score of 60 or higher who meet the inclusion criteria will be included in the study.

Hypothesis 1: The intervention group's level of nomophobia is lower than that of the control group.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Nomophobia Child Dependence Puzzle Activity Smart Phone Addiction

Age range

12 year–14 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Pamukkale University

Denizli, Kınıklı, 20160, Turkey (Türkiye)

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Score at least 60 points on the nomophobia scale
Be between the ages of 12 and 14
Written consent from parents and verbal consent from the child

Exclusion criteria

Be under 12 years of age and over 14 years of age
Have scored less than 60 points on the nomophobia scale

Treatment and study plan

Mosaic Puzzle Intervention

Other

This study aims to investigate the effect of mosaic puzzle application on nomophobia in adolescents. The data for the study will be collected over a 5-week period. The experimental group children will be asked to play mosaic puzzle games for 1 hour, 2 days a week for 5 weeks at a time deemed appropriate by the school under the supervision of the researcher. The control group children will not be given any application; they will only be observed, and a final test will be administered at the end of the 5 weeks. The study is planned as a single-center study, and a total of 30 children aged 12-14 with a nomophobia scale score of 60 or higher who meet the inclusion criteria will be included in the study.

Primary outcomes

Nomophobia Scale (NO) for the 9-18 Age Group

Time frame: From enrollment to the end of treatment at 10 weeks.

The Nomophobia Scale developed by Yıldırım and Correia (2015) is a Likert-type measure that assesses the level of fear experienced by children when they do not have access to their cell phones. The validity and reliability of the scale were studied by Özdemir and Bektaş (2020). The scale consists of 20 items. It is a 7-point Likert-type scale (1: Strongly disagree; 7: Strongly agree). The scale has four subscales: inability to access information, giving up comfort, inability to communicate, and loss of online connection. A score of 20 on the scale indicates no nomophobia, 21 ≤ NÖ Score < 60 indicates mild nomophobia, 60 ≤ NÖ Score < 100 indicates moderate nomophobia, and 100 ≤ NÖ Score ≤ 140 indicates severe nomophobia. The scale ranges from a minimum of 20 to a maximum of 140 points. As the score increases, the level of nomophobia increases. Individuals who score 61 or higher on the raw score can be classified as having 'severe or moderate' nomophobia.

Sponsors and collaborators

Lead sponsor

Rabia Nur TEKİ KESKİN

Other

Collaborators

Pamukkale University scientific research project department

Registry information

Official study title

The Effect of Mosaic Puzzle Game on Nomophobia in Adolescents: A Randomised Controlled Study

Important dates

Study start: 2025
Primary completion: 2025
Study completion: 2025
First posted: Jul 31, 2025
Registry last updated: Jul 31, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed